Streptozocin
- Generic Name
- Streptozocin
- Brand Names
- Zanosar
- Drug Type
- Small Molecule
- Chemical Formula
- C8H15N3O7
- CAS Number
- 66395-18-4
- Unique Ingredient Identifier
- 8H27GUR065
Overview
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
Background
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
Indication
For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).
Associated Conditions
- Metastatic Islet Cell Carcinoma
Clinical Trials
FDA Approved Products
Zanosar
Manufacturer:ESTEVE PHARMACEUTICALS, S.A.
Route:INTRAVENOUS
Strength:1 g in 10 mL
Approved: 2023/04/03
NDC:68118-100
Zanosar
Manufacturer:Teva Parenteral Medicines, Inc.
Route:INTRAVENOUS
Strength:100 mg in 1 mL
Approved: 2023/06/29
NDC:0703-4636
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath